Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Pfizer to end development of experimental obesity pill due to elevated liver enzymes By: CNBC.com News June 26, 2023 at 08:35 AM EDT Pfizer's two pills are part of the same class of obesity drugs as Novo Nordisk's blockbuster weight loss injections Ozempic and Wegovy. Read More >> Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Pfizer to end development of experimental obesity pill due to elevated liver enzymes By: CNBC.com News June 26, 2023 at 08:35 AM EDT Pfizer's two pills are part of the same class of obesity drugs as Novo Nordisk's blockbuster weight loss injections Ozempic and Wegovy. Read More >>